Henry Schein Inc(HSIC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 25.45 | EPS (ttm) | 3.43 | Insider Own | 15.22% | Shs Outstand | 111.9M | Perf Week | -3.39% |
| Market Cap | 9.73B | Forward P/E | 14.53 | EPS next Y | 11.63% | Insider Trans | 0.03% | Shs Float | 94.5M | Perf Month | -2.07% |
| Enterprise Value | 14.95B | PEG | 1.44 | EPS next Q | 1.36 | Inst Own | 98.68% | Short Float | 7.32% | Perf Quarter | 10.75% |
| Income | 0.40B | P/S | 0.72 | EPS this Y | 8.34% | Inst Trans | 1.32% | Short Ratio | 5.67 | Perf Half Y | 14.16% |
| Sales | 13.60B | P/B | 3.1 | EPS next 5Y | 10.09% | ROA | 3.62% | Short Interest | 6.91M | Perf YTD | 15.55% |
| Book/sh | 28.21 | P/C | 61.99 | EPS past 3/5Y | -5.75% 3.12% | ROE | 12.21% | 52W High | -5.26% ($92.18) | Perf Year | 29.55% |
| Cash/sh | 1.41 | P/FCF | 17.1 | Sales past 3/5Y | 1.4% 5.43% | ROIC | 7.03% | 52W Low | 40.98% ($61.94) | Perf 3Y | 18.21% |
| Dividend Est. | - | EV/EBITDA | 13.12 | EPS Y/Y TTM | 10.41% | Gross Margin | 29.3% | Volatility(W/M) | 1.88% 1.93% | Perf 5Y | 13.77% |
| Dividend TTM | - | EV/Sales | 1.1 | Sales Y/Y TTM | 6.49% | Oper. Margin | 5.98% | ATR (14) | 1.74 | Perf 10Y | 40.25% |
| Dividend Ex-Date | - | Quick Ratio | 0.73 | EPS Q/Q | 17.18% | Profit Margin | 2.96% | RSI (14) | 43.47 | Recom | 2.11 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.32 | Sales Q/Q | 6.73% | SMA20 | -2.3% ($89.39) | Beta | 0.84 | Target Price | $100.47 |
| Payout | - | Debt/Eq | 1.21 | Earnings | 2026/8/4 | SMA50 | -0.38% ($87.66) | Rel Volume | 0.94 | Prev Close | $87.97 |
| Employees | 25000 | LT Debt/Eq | 0.82 | EPS/Sales Surpr. | 2.45% 2.49% | SMA200 | 10.07% ($79.34) | Avg Volume(3M) | 1.22M | Price | $87.33 |
| IPO | 1995/11/3 | Option/Short | Yes/Yes | Trades | 11661 | Volume | 1,149,187 | Change | -0.73% |
Company
HSIC is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A global healthcare distribution company that supplies medical products and services to dental and medical practices. With dental supplies and equipment distribution as its core business, it operates a hybrid business model that combines specialized product manufacturing with cloud-based practice management software, making it a medical distribution stock.
Over the past 1 year, on the higher side
5% below its 1-year high.
HSIC makes money exceptionally well
5.98% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +8.3% this year.
Tap to view numbers
The price looks about right
Trading at 25.4 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +18.2% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 98.7%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
SASS 0.07%
CWS 0.04%
RSPH 0.02%
XHS 0.02%
FLV 0.02%It ranks #4 in the industry
Based on market cap of $10B.
HSIC $10B PER 25.4
MCK $103B PER 23.6
COR $61B PER 23.9
CAH $55B PER 32.6
FAQ
What kind of company is HSIC?
HSIC belongs to the Healthcare sector and operates in the Medical Distribution industry.
What is the market cap of HSIC?
The market cap of HSIC is approximately $9.7B, ranking 956 within its sector.
What is the P/E ratio of HSIC?
HSIC has a P/E ratio of approximately 25.4x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for HSIC?
HSIC has recorded a 52-week high of $92.18 and a low of $61.94.
